Bronchiectasis: Clinical Trials

2 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
Aztreonam lysine, Placebo - Bronchiectasis Adult
Phase 4TerminatedUniversity of Dundee342019-10-192026-01-12
Targeted AntiBiotics for Chronic Pulmonary Diseases
Piperacillin/tazobactam, Ciprofloxacin - COPD, Respiratory Tract Infections
Phase 4TerminatedChronic Obstructive Pulmonary Disease Trial Network, Denmark512018-01-102023-05-25

Narrower conditions

Asthma (1)  ·  Pseudomonas Infections (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Bronchial Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Aztreonam (1)  ·  Ciprofloxacin (1)  ·  Piperacillin, Tazobactam Drug Combination (1)

Sponsors

Chronic Obstructive Pulmonary Disease Trial Network, Denmark (1)  ·  University of Dundee (1)

Countries

Denmark (1)  ·  United Kingdom (1)

Top investigators

James Chalmers, MBChB, MRCP (1)  ·  Jens-Ulrik Jensen, MD, Consultant, Phd (1)

Results publications

PMID 31238116, PMID 35124256, PMID 38844921

NIH funding

2018 (1)